Log In
Print
BCIQ
Print
Print this Print this
 

HibTITER (NU 300)

  Manage Alerts
Collapse Summary General Information
Company Nuron Biotech Inc.
DescriptionHaemophilus influenza type b vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase III
Standard IndicationHaemophilus
Indication DetailsPrevent Haemophilus influenza type b infection
Regulatory Designation

Partner

Mitsubishi Tanabe Pharma Corp.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today